- In July 2024, A study published by the Journal of Medical Services highlighted the critical importance of effective temperature management in treating patients during shock. It emphasized the integration of intravascular warming systems as a key intervention to prevent hypothermia and improve patient outcomes. The study reinforced the value of precise temperature control in critical care
- In March 2024, ZOLL unveiled advanced intravascular warming systems, including the Thermogard and IQool systems. These devices use internal catheters and external pads to regulate patient temperature accurately. By managing both core and surface temperatures, they ensure better precision, contributing to improved patient outcomes and enhanced control over temperature fluctuations during critical conditions
- In March 2024, The CHILL-SHOCK trial evaluated the safety and efficacy of targeted temperature control (TTC) in patients with cardiogenic shock (CS). The trial focused on intravascular warming systems as a potential adjunct therapy to enhance patient survival and mitigate the high mortality rates commonly seen in CS, providing promising insights into temperature management
